SUPN - Supernus Pharmaceuticals reports mixed Q1 results; reaffirms FY24 outlook
2024-05-08 16:56:17 ET
More on Supernus Pharmaceuticals
- Supernus Pharmaceuticals: Moving Through An 'Inflection Year'
- Supernus stock slides as FDA rejects Parkinson's disease infusion device
- Seeking Alpha’s Quant Rating on Supernus Pharmaceuticals
- Historical earnings data for Supernus Pharmaceuticals